2019 Winter Symposium Speaker Biographies

Sarvan Kumar Bhamidipati, Director, Decision Sciences, Axtria

Sravan Bhamidipati is a Director in Decision Sciences at Axtria. Sravan has over 10 years of analytics and consulting experience in the pharma Industry. He has rich experience in conducting secondary data analytics, predictive modeling and applying Machine Learning techniques on patient data – including patient pharma / medical claims, electronic health records in a variety of therapeutic areas like oncology, cardiovascular diseases, etc. Sravan has expertise in using a wide mix of analytical tools for building Machine Learning solutions on Patient Claims/EHR data using Python, R and h20.ai.


Vijay Chickarmane, Manager, Decision Sciences, Axtria

Vijay Chickarmane is a Manager in Decision Sciences at Axtria. Vijay develops innovative solutions to pharma management science problems. His focus area is in developing Machine Learning models based upon patient level data and other data sources to extract insights that are actionable for brand marketing teams. Prior to his career at Axtria, Vijay spent two years as a consultant in a large consulting firm as part of their Machine Learning division, where he developed predictive models to answer complex problems in a variety of industries including healthcare, auto insurance, energy, and finance. Before that he was a research scientist at Caltech where he developed computational models using techniques such as agent-based simulations, network inference and applied mathematical modeling to understand stem cell gene regulatory and signaling networks. Vijay earned a PhD in theoretical physics and has contributed towards data analysis and detector simulation to high energy physics projects. He has authored over 40 well-regarded and highly-cited publications in data analysis and mathematical modeling as applied to problems in physics and biology.


Dr. Harietta Eleftherochorinou, Senior Principal, Machine Learning & AI Solutions, Real World & Analytics Solutions, IQVIA

Dr. Harietta Eleftherochorinou leads globally the design and development of large-scale Machine Learning (ML) and Artificial Intelligence (AI) technology solutions in IQVIA. She has over 15 years of experience in transforming drug development and healthcare using ML/AI, one patient at a time. Highlights of her work include large-scale big-data lake implementations for ML/AI-enabled commercial applications in big pharma; Real-World ML/AI technology platforms for scalable disease diagnostics, disease progression predictions, physician targeting; ML-led forecasting for increased precision, innovative patient-physician targeting applications for drug addressable market realization. Harietta has achieved several distinctions throughout her career, including prestigious Welcome Trust and European Union awards for early research on ML/AI-led diagnostics, the Deloitte Outstanding Achievement for exceptional client delivery and the UK Cloud Award of the Year on Innovation in Big Data Analytics. She is invited as a speaker to several commercial and academic forums and has published multiple scientific papers in world class, peer reviewed journals. Academically, she holds an MEng in Electrical and Computer Engineering (Hons); an MSc in Bioinformatics and Systems Biology (Distinction) and a PhD in Medicine from Imperial College London.


Kent Groves, PhD, VP Global Health Strategy, Merkle Health

Kent is a Vice President of Strategy, and leads Merkle’s Global Health Strategy practice. He has been consulting in the areas of pharmaceutical and animal health strategy for more than 15 years. He is published extensively in a variety of journals including, Research in Social and Administrative Pharmacy, Formulary, the Journal of Clinical Pharmacy and Therapeutics, and the Journal of Database Marketing. Kent is recognized as a subject matter expert in the area of factors influencing physician prescribing, is the author of several white papers, and most recently was the lead author for the chapter on Prescribing Behavior in Social and Behavioral Aspects of Pharmaceutical Care, 3rd Edition, published in 2016.

Kent has worked with a number of clients in the pharmaceutical, healthcare, and animal health vertical including Sanofi (Genzyme, Chattem and Merial), AstraZeneca, GSK, Elanco, Novartis, Abbvie, BMS, Boehringer Ingelheim, Merck and Gilead, focusing on engagement and communication strategy in the US, Canada, Europe and Australasia. He has a PhD in Pharmaceutical Strategy and Policy from Dalhousie University in Halifax, NS, and holds the position of Assistant Professor, Clinical Pharmacy, at the James L Winkle College of Pharmacy, University of Cincinnati.


John Lin, Senior Vice President, Analytic Sciences, Epsilon Health

John is a Senior Vice President in the Analytic Consulting Group at Epsilon. He leads the analytic sciences practice that supports Epsilon’s Healthcare clients. He has over 25 years of experience in predictive modeling, targeting/segmentation, measurement and profiling with the most recent twelve years focused on consulting in the pharmaceutical industry. John specializes in the tactical implementation of statistical tools and techniques to maximize the efficiency of clients’ marketing efforts. His areas of expertise include machine learning/AI, modeling techniques, experimental design and patient-level data (PLD) analyses.

John is a long-time member of PMSA and he is frequent speaker at various conferences including many PMSA Conferences and Symposiums. John has an M.S. from University of Mississippi in Mathematics and an M.S. and an A.B.D from University of Memphis in Applied Statistics.


Olympia Mantsios, Associate Director, Analytics, Merkle Health

Olympia has been with Merkle since 2014, and holds the position of Associate Director of Analytics. Olympia has extensive experience with marketing analytics across both consumer and HCP campaigns. During her tenure with Merkle, she has worked with a variety of clients, across a number of different therapeutic areas and a number of brands at different stages of their product lifecycle. Her experience includes work leading accounts focused on Diabetes, Oncology, Multiple Sclerosis, and Dermatology. Her clients have grown to depend on her cross therapeutic insight, and unique perspective leveraging analytics to develop actionable (and measurable) strategy. She is a contributor to Merkle’s Health Thought Leadership panel, and sought after across teams for her perspective and insight. Prior to joining Merkle, OIympia had roles at Digitas Health and Saatchi Health, where she focused on digital marketing analytics in areas of Women’s Health, Arthritis, Multiple Sclerosis, COPD, and others.

Olympia holds an MBA in Marketing from Baruch College, City University of New York.


Arif Nathoo, CEO and Co-Founder, Komodo Health

Arif Nathoo, M.D., is co-founder & chief executive officer at Komodo Health where he oversees data sciences, engineering, and product development initiatives for the company. He has spent the past 15 years in healthcare and life sciences leadership roles. Before Komodo Health, Arif was a leader in McKinsey's Healthcare practice where he was responsible for helping enterprise healthcare address issues in corporate strategy, finance, sales and marketing, and organization building. He co-led McKinsey's Medical Affairs Practice, which created analytic products and services to improve non-promotional engagement between industry and providers.

He has conducted research in novel instructional technologies and medical devices, with multiple publications in peer-reviewed journals. Arif graduated magna cum laude with Highest Honors from Harvard University with an A.M. in molecular and cellular biology, an M.D. from Harvard Medical School, and M.P.A. in health policy from Harvard Kennedy School.


François-Xavier Rousselot, VP of Data Analytics and AI/ML Strategy, Aptus Health

With over 20 years of experience in digital marketing and services, Mr. Rousselot is responsible for setting and executing the company’s strategy around next-gen analytics applications such as Artificial Intelligence (AI), Machine Learning (ML), and more. Prior to Aptus Health, he worked on applications of Machine Learning and AI across different sectors, with a strong focus on Media Analytics. He has also held analytics positions at the French Embassy in Beirut, the Marketing department of the French telecommunications company SFR, and led cloud computing for F-Secure Corporation (North and Latin America).

Mr. Rousselot is an Affiliate Professor at IE Business School and has experience coaching multinational corporations and startups (TripAdvisor, PWC, HEC and Polytechnique’s Incubator to name a few) on their data projects and helping them sharpen their analytics capabilities. François-Xavier Rousselot is a graduate from HEI (1997) and an alumni of the prestigious IE Business School (International MBA - 2008).


Eleanor Tipa, Vice President, Analytic Sciences, Epsilon Health

Eleanor is a Vice President in the Analytic Consulting Group at Epsilon. Eleanor has 20 years of experience in marketing analytics across various industries with special focus in the healthcare vertical. She specializes in the design, management, and execution of analytic projects that support the optimization of clients’ multichannel marketing campaigns. Her areas of expertise include the use of advanced statistical techniques in predictive modeling, segmentation and profiling, experimental design, and multichannel campaign performance measurement including media mix models and attribution models.

Eleanor holds a Ph.D. in Statistics from the Pennsylvania State University. Eleanor has given talks in various analytic conferences such as the Conference on Statistical Practice and PMSA.


Fred Trotter, CTO, CareSet

Fred Trotter is a healthcare data journalist and author. He is a founder of CareSet Systems and The DocGraph Journal, and co-author of the first Health IT O’Reilly book Hacking Healthcare. Fred Trotter won the 2016 healthcare data liberator award for his work opening significant healthcare data sets.

Fred’s technical commentary and data journalism work have been featured in several online and print journals including Wired, Forbes, U.S. News, NPR, Government Health IT, and Modern Healthcare. As a technology entrepreneur, he is an alumnus of multiple successful technical startups including Rackspace, Exault (purchased by Verisign), and ClearHealth (the top Open Source EHR company).


Jean-Patrick Tsang, President, Bayser

Jean-Patrick Tsang is the Founder and President of Bayser, a Chicago-based consulting firm dedicated to pharmaceuticals sales and marketing. JP has worked on 250+ projects to date including ROI optimization, data strategy, and segmentation & targeting to mention just these. JP publishes and gives talks on a regular basis and runs one-day classes on various subjects related to data and analysis. In a previous life, JP deployed Artificial Intelligence to automate the design of payloads for satellites and was the adviser of two PhD Students. JP holds a Ph.D. in Artificial Intelligence from Grenoble University and an MBA from INSEAD in France. He was also the Recipient of the PMSA Lifetime Achievement Award in 2015. He can be reached at (847) 920-1000 or This email address is being protected from spambots. You need JavaScript enabled to view it..


Robin Varghese, Principal, CustomerInsights.AI

With over 18 years of experience, Robin specializes in integrating Analytics & Technology to help global companies solve problems through higher levels of efficiency and quality. With a strong Life Sciences based analytics experience, he has been guiding CustomerInsights.AI’s Data Sciences Team & AI Research Lab to develop innovative AI solutions & platforms.